THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
KUNDRA, VIKAS
申请号：
CA2810838
公开号：
CA2810838A1
申请日:
2011.09.08
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
Methods and composition for cell-based therapy as well as somatostatin receptor - based therapy are described. For example, in certain aspects methods for administering an anti-tumor therapy using a signaling defective somatostatin receptor mutant are described. Furthermore, the invention provides compositions and methods involve a somatostatin constitutively active somatostatin receptor mutant.
